Patent information
Equigerminal has 2 patent families that complement each other:
-
- Viral Peptides - WO2015094001A1 protects viral peptides for diagnosis and therapeutics purposes of the New Equine Virus (NEV).
- Antiviral Composition - WO2016195522A2 protects a class of antivirals to treat viral infections.
With 10 international patent processes and 1 biological patent deposit.
-
4 granted patents:
- Viral Peptides - EP3083659B- European Patent 🇪🇺
- Viral Peptides - GB2526222B - United Kingdom 🇬🇧
- Antiviral Composition - GB2544439B - United Kingdom 🇬🇧
- Antiviral Composition - AU2017271995B - Australia 🇦🇺
